Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 15.35% is 865% above its 5-year average of 1.59%, near the high end of its 5-year range (-38.94%–19.50%).
13.53% above its 12-month average of 13.52%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 15.21%.
OPERATING MARGIN
15.35%
OPERATING MARGIN AVG TTM
13.52%
OPERATING MARGIN AVG 3Y
10.54%
OPERATING MARGIN AVG 5Y
1.59%
OPERATING MARGIN AVG 10Y
7.08%
OPERATING MARGIN AVG 15Y
9.68%
OPERATING MARGIN AVG 20Y
-62.05%
CURRENT VS TTM AVG
+13.53%
CURRENT VS 3Y AVG
+45.63%
CURRENT VS 5Y AVG
+865.26%
CURRENT VS 10Y AVG
+116.79%
CURRENT VS 15Y AVG
+58.49%
CURRENT VS 20Y AVG
+124.74%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 384 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
ANI Pharmaceuticals, Inc.
Market Cap
$1.65B
Operating Margin
15.35%
TTM Avg
13.52%
3Y Avg
10.54%
5Y Avg
1.59%
Market Cap
$1.65B
Operating Margin
-5.55%
TTM Avg
-16.51%
3Y Avg
-27.71%
5Y Avg
-34.02%
Market Cap
$1.71B
Operating Margin
11.69%
TTM Avg
-8.16%
3Y Avg
-10.59%
5Y Avg
-4.68%
Market Cap
$1.76B
Operating Margin
1.20%
TTM Avg
-1.69%
3Y Avg
-4.84%
5Y Avg
-5.86%
Market Cap
$1.52B
Operating Margin
0.09%
TTM Avg
-3.29%
3Y Avg
-12.30%
5Y Avg
-11595.24%
Market Cap
$1.78B
Operating Margin
-651.67%
TTM Avg
-787.38%
3Y Avg
-968.58%
5Y Avg
-820.03%
Market Cap
$1.78B
Operating Margin
-737.04%
TTM Avg
-849.82%
3Y Avg
-849.82%
5Y Avg
-849.82%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ANI Pharmaceuticals, Inc. (ANIP) | $1.65B | 15.35% | 13.52% | 10.54% | 1.59% |
| Alphatec Holdings, Inc. (ATEC)vs › | $1.65B | -5.55% | -16.51% | -27.71% | -34.02% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.71B | 11.69% | -8.16% | -10.59% | -4.68% |
| Certara, Inc. (CERT)vs › | $1.57B | 1.86% | 2.28% | 0.69% | -0.42% |
| Alignment Healthcare, Inc. (ALHC)vs › | $1.76B | 1.20% | -1.69% | -4.84% | -5.86% |
| Eton Pharmaceuticals, Inc. (ETON)vs › | $1.52B | 0.09% | -3.29% | -12.30% | -11595.24% |
| GH Research PLC (GHRS)vs › | $1.52B | 0.00% | 0.00% | 0.00% | 0.00% |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.78B | -651.67% | -787.38% | -968.58% | -820.03% |
| Generate Biomedicines, Inc. (GENB)vs › | $1.78B | -737.04% | -849.82% | -849.82% | -849.82% |
| Braveheart Bio, Inc. (BRVE)vs › | $1.51B | N/A | N/A | N/A | N/A |
Gross Margin
51.0%
Operating Margin
15.3%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 15.21% |
| 2026-03-31 | 16.30% |
| 2025-12-31 | 19.50% |
| 2025-09-30 | 10.02% |
| 2025-06-30 | 6.57% |
| 2025-03-31 | 13.29% |
| 2024-12-31 | -2.30% |
| 2024-09-30 | -13.83% |
| 2024-06-30 | 3.74% |
| 2024-03-31 | 14.78% |
| 2023-12-31 | 5.11% |
| 2023-09-30 | 13.61% |
| 2023-06-30 | 10.64% |
| 2023-03-31 | 9.27% |
| 2022-12-31 | 1.93% |
| 2022-09-30 | -5.96% |
| 2022-06-30 | -17.48% |
| 2022-03-31 | -29.77% |
| 2021-12-31 | -38.94% |
| 2021-09-30 | -6.84% |
| 2021-06-30 | -31.99% |
| 2021-03-31 | 5.59% |
| 2020-12-31 | 0.58% |
| 2020-09-30 | 5.29% |
| 2020-06-30 | -23.33% |
| 2020-03-31 | -15.76% |
| 2019-12-31 | -9.74% |
| 2019-09-30 | 14.27% |
| 2019-06-30 | 17.09% |
| 2019-03-31 | 8.32% |
| 2018-12-31 | 20.04% |
| 2018-09-30 | 19.95% |
| 2018-06-30 | 15.37% |
| 2018-03-31 | 14.06% |
| 2017-12-31 | 15.61% |
| 2017-09-30 | 19.37% |
| 2017-06-30 | 15.62% |
| 2017-03-31 | 12.63% |
| 2016-12-31 | 3.40% |
| 2016-09-30 | 20.56% |
| 2016-06-30 | 16.57% |
| 2016-03-31 | 27.57% |
| 2015-12-31 | 34.75% |
| 2015-09-30 | 42.31% |
| 2015-06-30 | 43.11% |
| 2015-03-31 | 50.89% |
| 2014-12-31 | 51.21% |
| 2014-09-30 | 47.16% |
| 2014-06-30 | -37.01% |
| 2014-03-31 | 32.07% |
| 2013-12-31 | 32.85% |
| 2013-09-30 | 10.34% |
| 2013-06-30 | -61.36% |
| 2013-03-31 | -2028.76% |
| 2012-12-31 | -184.59% |
| 2012-09-30 | -4833.14% |
| 2012-06-30 | 100.00% |
| 2012-03-31 | -6080.64% |
| 2011-12-31 | -9002.41% |
| 2011-09-30 | -7127.65% |
| 2011-06-30 | -16128.96% |
| 2011-03-31 | -27726.18% |
| 2010-12-31 | -9249.60% |
| 2010-09-30 | -21540.93% |
| 2010-06-30 | 0.00% |
| 2010-03-31 | -392.98% |
| 2009-12-31 | -1353.91% |
| 2009-09-30 | -60718.22% |
| 2009-06-30 | -4012.31% |
| 2009-03-31 | -5936.55% |
| 2008-12-31 | -51.50% |
| 2008-09-30 | -8138.51% |
| 2008-06-30 | -21313.98% |
| 2008-03-31 | -8701.48% |
| 2007-12-31 | -611.45% |
| 2007-09-30 | -4902.97% |
| 2007-06-30 | -3788.26% |
| 2007-03-31 | -3731.72% |
| 2006-12-31 | 70.71% |
| 2006-09-30 | -618.24% |
| 2006-06-30 | -1309.58% |
| 2006-03-31 | -3926.21% |
| 2005-12-31 | -1848.66% |
| 2005-09-30 | -2247.38% |
| 2005-06-30 | -5885.41% |
| 2005-03-31 | -10002.58% |
| 2004-12-31 | -7678.28% |
| 2004-09-30 | -27450.46% |
| 2004-06-30 | -52848.81% |
| 2004-03-31 | -33795.80% |
| 2003-12-31 | 3134.66% |
| 2003-09-30 | -5665.20% |
| 2003-06-30 | 0.00% |
| 2003-03-31 | -1476.26% |
| 2002-12-31 | -22.34% |
| 2002-09-30 | -83.22% |
